Please login to the form below

Not currently logged in
Email:
Password:

Inovio

This page shows the latest Inovio news and features for those working in and with pharma, biotech and healthcare.

Inovio plans late-stage COVID-19 vaccine study in second quarter 2021

Inovio plans late-stage COVID-19 vaccine study in second quarter 2021

On Monday, Inovio also announced that it has signed a collaboration and licence agreement for INO-4800 with Chinese biotech Advaccine Biopharmaceuticals Suzhou. ... Inovio and Advaccine are already working together on the clinical development of INO-4800

Latest news

  • Inovio hit with FDA hold on COVID-19 vaccine trial Inovio hit with FDA hold on COVID-19 vaccine trial

    The US Food and Drug Administration (FDA) has placed a temporary hold on Inovio Pharmaceuticals’ mid-to-late stage coronavirus vaccine trial. ... Importantly, the clinical hold is not due to the occurrence of any adverse events related to the vaccine,

  • CEPI says $2bn is needed for COVID-19 vaccine development CEPI says $2bn is needed for COVID-19 vaccine development

    CEPI has already invested $4.4m in partnering agreements with Novavax and The University of Oxford to rapidly develop COVID-19 vaccine candidates, and it also announced initial funding to Inovio

  • Trial backs Inovio/Sanofi combo in hard-to-treat brain cancer Trial backs Inovio/Sanofi combo in hard-to-treat brain cancer

    Results at six months demonstrated 75% of patients were progression-free. A combination of three cancer immunotherapy drugs from Inovio and Sanofi/Regeneron has shown impressive results in glioblastoma multiforme (GBM), ... Newly-diagnosed GBM patients

  • Takeda gets FDA fast-track status for Zika vaccine Takeda gets FDA fast-track status for Zika vaccine

    Last year Inovio Pharma and GeneOne Life Sciences reported phase I data with their synthetic GLS-5700 DNA vaccine in the New England Journal of Medicine (NEJM), concluding that it was

  • AZ adds cancer vaccine to immuno-oncology portfolio AZ adds cancer vaccine to immuno-oncology portfolio

    AstraZeneca has signed a strategic-level licensing deal with Inovio for cancer vaccines that flesh out its cancer immunotherapy pipeline. ... The result is what Inovio claims is a 'best-in-class' T cell-stimulating therapy, generating fully functional

More from news
Approximately 4 fully matching, plus 9 partially matching documents found.

Latest Intelligence

  • COVID-19: the race to find a vaccine COVID-19: the race to find a vaccine

    Inovio Pharmaceuticals began testing its plasmid candidate in humans in April, putting it at the head of a pack of six groups that have DNA vaccines in development.

  • Developing a COVID-19 vaccine Developing a COVID-19 vaccine

    The CEPI has currently initiated eight COVID-19 vaccine developments with Curevac, Inovio Pharmaceuticals, Moderna, Novavax, The University of Hong Kong, The University of Oxford, The University of Queensland and a

  • Deal Watch February 2017 Deal Watch February 2017

    Amendment to 2015 agreement. 80. Inovio Pharmaceuticals/  ApolloBio Corporation. VGX-3100, DNA immunotherapy to treat pre-cancers caused by human papillomavirus (phase II).

  • Pharma deals in August 2015 Pharma deals in August 2015

    AstraZeneca deals. Subject. Headline $m. Inovio. Cancer vaccines. 727. Heptares. HTL 1071 and A2A receptor blocking compounds. ... Acquisition ‐ company. 847. Inovio. AZ/Medimmune. INO‐3112 vaccine in P1/2 for cervical and head &neck cancer.

  • Deal Watch table for September 2013 Deal Watch table for September 2013

    483. BioFire Diagnostics / BioMerieux. Acquisition. Invitro diagnostic company. 450. Inovio Pharma / Roche Holdings.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Ask the writers: Transitioning from academia to medical writing
Porterhouse Medical's talented writers talk about their transition from academia and give advice to those people considering a career in medical writing...
Strategic launch planning: familiar framework, new mindset
By James Aird...
Guide
How to embrace behavioural science principles in healthcare MR...